We are live on ! Find out more
GA

Gagnon Advisors Portfolio holdings

AUM $136M
1-Year Est. Return 21.55%
This Fund
S&P 500
This Quarter Est. Return
+15.82%
1 Year Est. Return
+21.55%
3 Year Est. Return
+78.18%
5 Year Est. Return
+93.01%
10 Year Est. Return
+1,298.31%
AUM
$155M
AUM Growth
+$23.5M
Cap. Flow
-$198K
Cap. Flow %
-0.13%
Top 10 Hldgs %
60.45%
Holding
29
New
2
Increased
4
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
TMCI icon
Treace Medical Concepts
TMCI
+$3.15M
2
NVDA icon
NVIDIA
NVDA
+$1.96M
3
FRSH icon
Freshworks
FRSH
+$1.55M
4
FIVN icon
FIVE9
FIVN
+$1.51M
5
VRN
Veren
VRN
+$1.07M

Sector Composition

Rank Sector Weight
1 Healthcare 30.55%
2 Technology 28.48%
3 Industrials 20.85%
4 Energy 14.23%
5 Real Estate 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSIX
1
Power Solutions International
PSIX
$641M
$15.6M 10.06%
757,744
CDNA icon
2
CareDx
CDNA
$1.97B
$12.9M 8.33%
412,875
-197,461
-32% -$4.91M
WGS icon
3
GeneDx Holdings
WGS
$2.05B
$10.8M 6.99%
255,059
EPD icon
4
Enterprise Products Partners
EPD
$82.5B
$9.89M 6.39%
339,877
AL
5
DELISTED
Air Lease Corp
AL
$8.9M 5.75%
196,479
NVGS icon
6
Navigator Holdings
NVGS
$1.37B
$8.31M 5.37%
517,066
AMRC icon
7
Ameresco
AMRC
$1.09B
$7.81M 5.05%
205,948
+12,623
+7% +$390K
BLFS icon
8
BioLife Solutions
BLFS
$1.55B
$6.87M 4.43%
274,217
SCWX
9
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$6.59M 4.25%
744,444
PROF
10
Profound Medical
PROF
$263M
$5.95M 3.84%
747,226
EXAS
11
DELISTED
Exact Sciences
EXAS
$5.92M 3.83%
86,972
-18,158
-17% -$1.02M
EQIX icon
12
Equinix
EQIX
$103B
$5.86M 3.78%
6,600
BL icon
13
BlackLine
BL
$1.8B
$5.72M 3.69%
103,692
FRSH icon
14
Freshworks
FRSH
$3.11B
$5.4M 3.49%
470,434
+129,483
+38% +$1.55M
FIVN icon
15
FIVE9
FIVN
$2.12B
$4.81M 3.11%
167,386
+41,846
+33% +$1.51M
AOSL icon
16
Alpha and Omega Semiconductor
AOSL
$931M
$4.46M 2.88%
120,196
-69,161
-37% -$2.63M
VERX icon
17
Vertex
VERX
$2.04B
$4.45M 2.87%
115,594
ZUO
18
DELISTED
Zuora, Inc.
ZUO
$4.43M 2.86%
514,247
VRN
19
DELISTED
Veren
VRN
$3.83M 2.47%
623,113
+149,168
+31% +$1.07M
ETWO
20
DELISTED
E2open Parent Holdings
ETWO
$3.44M 2.22%
780,745
TMCI icon
21
Treace Medical Concepts
TMCI
$284M
$2.84M 1.84%
+489,891
New +$3.15M
DV icon
22
DoubleVerify
DV
$1.69B
$2.28M 1.47%
135,410
NVDA icon
23
NVIDIA
NVDA
$4.72T
$2.01M 1.3%
+16,555
New +$1.96M
PCRX icon
24
Pacira BioSciences
PCRX
$1.06B
$2.01M 1.3%
133,390
KLTR icon
25
Kaltura
KLTR
$206M
$1.4M 0.9%
1,029,708

Similar funds

Gagnon Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Gagnon Advisors held 29 positions worth $155M, up 18% from $131M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Gagnon Advisors's Q3 2024 filing shows 2 new, 4 increased, 3 reduced and 2 closed positions. Its largest new stake was Treace Medical Concepts: 489,891 shares worth $2.84M. The largest sale was CareDx, an estimated $4.91M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 29% a quarter earlier, followed by Technology and Industrials.

  • Gagnon Advisors's largest Q3 2024 buy was Treace Medical Concepts: 489,891 shares worth $2.84M.
  • Gagnon Advisors added most to Freshworks in Q3 2024, an estimated $1.55M increase.
  • Gagnon Advisors's biggest Q3 2024 reduction was CareDx, cutting an estimated $4.91M.
  • Gagnon Advisors fully exited Standard BioTools in Q3 2024, selling an estimated $1.19M.
  • Gagnon Advisors's ten largest holdings make up 60% of its $155M portfolio in Q3 2024.
  • Gagnon Advisors opened 2 new positions and closed 2 in Q3 2024.
  • Gagnon Advisors's portfolio value rose 18% quarter-over-quarter to $155M.

Based on Gagnon Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.